102 results
Page 2 of 6
S-8
EX-99.3
kjbxxj fw3q4t1
14 Jan 22
Registration of securities for employees
5:04pm
8-K
EX-99.2
d94hakv9
15 Nov 21
Regulation FD Disclosure
11:32am
424B5
7hpl68xsqkdu0n
12 Nov 21
Prospectus supplement for primary offering
4:09pm
8-K
4z2h9imzwks15z36o
17 Jun 21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
8:13am
8-K
EX-99.1
vx004mnwxyo
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
8-K
EX-1.1
mfbyd97ht2yzef kr
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
424B5
basloq6e7l6h3
19 Mar 21
Prospectus supplement for primary offering
4:04pm
424B5
5b03485 qyqcmv13a
17 Mar 21
Prospectus supplement for primary offering
5:07pm
8-K
70z0ad25m
11 Mar 21
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
8:08am